Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2003
08/21/2003WO2003004665A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
08/21/2003WO2003002609A3 Dual-specific ligand and its use
08/21/2003WO2002101054A3 Process for the preparation of d-pantothenic acid and/or salts thereof
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002077236A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002070695A3 Tumor associated proteins
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002061090A3 Prokaryotically produced antibodies and uses thereof
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002057418A3 Methods of producing polyketide synthase mutants and compositions and uses thereof
08/21/2003WO2002051238A3 Recombinant dna vectors for expression of somatotropins
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002042467A8 Aspergillus fumigatus profilin
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002029083A3 Industrial-scale serum-free production of recombinant proteins in mammalian cells
08/21/2003WO2002029041A3 32146 and 57259, novel human transporters and uses thereof
08/21/2003WO2002004022A3 High fidelity polymerases and uses thereof
08/21/2003WO2001085792A3 Mu-1, member of the cytokine receptor family
08/21/2003WO2001010453A3 Bifidobacteria capable of preventing diarrhea
08/21/2003US20030159179 Genetic engineered transgenic plant; controlling,germination
08/21/2003US20030159160 Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158398 Central nervous system disorders; psychological disorders
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158385 Novel fungal lipase
08/21/2003US20030158383 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158379 A DNA molecules encoding the proteins, used in the treatment of bone, connective tissue, tendon, ligament, wound healing and defects to tissues, animal growth factors, cell differentiation of embryonic and stem cells
08/21/2003US20030158136 Materials and methods relating to immune responses to fusion proteins
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030158070 For use in cleaning formulations
08/21/2003US20030157716 Recombinational cloning using nucleic acids having recombination sites
08/21/2003US20030157706 High throughput method, apparatus and kit for plating microorganisms and cell cultures
08/21/2003US20030157695 Marine actinomycete taxon for drug and fermentation product discovery
08/21/2003US20030157694 Mutant actinosynnema pretiosum strain with increased maytansinoid production
08/21/2003US20030157684 Microbial B-glucuronidase genes, gene production and uses thereof
08/21/2003US20030157680 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use
08/21/2003US20030157677 Comprises kluyveromyces polypeptide with oxidoreductase activity for generation of 4-haloacetoacetate ester and 4-halo-3- hydroxybutyrate ester
08/21/2003US20030157675 Transforming saccharomyces or pichia with nucleotide sequences which code xylose reductase (XR), xylitol dehydrogenase (XID), and xylulokinase for converting cellulose, hemicellulos and lignin into ethanol
08/21/2003US20030157674 Process for the biological production of 1,3-propanediol with high titer
08/21/2003US20030157673 Genes involved in cyclododecanone degradation pathway
08/21/2003US20030157672 Nitrilase from rhodococcus rhodochrous ncimb 11216
08/21/2003US20030157670 Capsaicin-decomposing/synthesizing enzymes and a method for producing the same
08/21/2003US20030157667 Method for producing L-amino acids using bacteria belonging to the genus escherichia
08/21/2003US20030157666 Novel nucleotide sequences coding for the citE gene
08/21/2003US20030157665 Heat-stable D-aminoacylase
08/21/2003US20030157664 Comprises genetically engineered, stable and functional oxidoreductase (FDH) for preparing chiral compounds such as amino acids
08/21/2003US20030157659 Proteins isolated from cyanobacteria
08/21/2003US20030157658 Polypeptides having beta-1,4-GalNAc transferase activity
08/21/2003US20030157657 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157656 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157655 Invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3-and an alpha 2,8- activity; glycosyltransferases obtained from Campylobacter species, including C.jejuni
08/21/2003US20030157652 Comprises nucleotide sequences coding acetyl-CoA carboxylase (ACCase) from streptomyces for generating secondary metabolites in culture such polyketides
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157646 Microbially expressed thermotolerant phytase for animal feed
08/21/2003US20030157645 Subtilisin variants with improved characteristics
08/21/2003US20030157643 Synthetic nucleic acids from aquatic species
08/21/2003US20030157642 Bacillus genetically engineeered for improved expression of secretion factor G (SECG) and heterologous proteins
08/21/2003US20030157636 Methylotrophic bacterium for the production of recombinant proteins and other products
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157595 Fungal culture for generating neutral or alkaline glucanases for biopolishing, defribillating, bleaching, dyeing, or desizing textiles; laundry detergents
08/21/2003US20030157594 Cell-free extract and glycoprotein synthesis system
08/21/2003US20030157593 Novel fructosyl peptide oxidase
08/21/2003US20030157591 Processing a plurality of samples contained in associated sample vessels and fermenting the plurality of samples in the sample vessels
08/21/2003US20030157589 Detecting bactericides/enzyme inhibitor which prevent propagtion of bacterium associated with tuberculosis and leprosy; desaturases (DES); drug screening
08/21/2003US20030157578 Providing a yeast cell containing an aequorin-encoding deoxyribonucleic acid sequence expressibly linked to a consituttive yeast promoter, incubating the yeast cell, measuring the amount of aequorin produced
08/21/2003US20030157552 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
08/21/2003US20030157551 Attenuated Coryneform bacteria, which express attenuated amounts MtrA and/or MtrB proteins or gene products that have response regulator or histidine protein kinase activity
08/21/2003US20030157550 Kit for direct RT-PCR on oligonucleotide-immobilized PCR microplates
08/21/2003US20030157536 Controlling transcription factor; genetic engineering expression vector
08/21/2003US20030157533 Nucleic acid labeling by Thermoanaerobacter thermohydrosulfuricus DNA polymerase I variants
08/21/2003US20030157516 Medical diagnosis; binding with adenine
08/21/2003US20030157508 Genetic engineering; gene therapy
08/21/2003US20030157501 Measuring gene expression; calibration sensitivity to cancer, thyroid disease
08/21/2003US20030157492 Method to isolate DNA
08/21/2003US20030157491 HarA polypeptides and nucleic acids, and related methods and uses thereof
08/21/2003US20030157486 Methods to identify signal sequences
08/21/2003US20030157476 Immortalized human keratinocyte cell line
08/21/2003US20030157474 Removal antigens from blood
08/21/2003US20030157230 Process for stabilizing proteins in an acidic environment with a high-ester pectin
08/21/2003US20030157219 Foodstuffs containing mucorales fungi
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157123 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157121 Virulence genes, proteins, and their use
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157068 Method of treatment of osteoporosis with compositions of red rice fermentation products
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003US20030157022 Non-invasive localization of a light-emitting conjugate in a mammal
1 ... 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 ... 1489